论文部分内容阅读
Objectives To investigate efficacy and safety of thrombolysis and anticoagulation with low dose of urokinase (UK) and low molecular weight heparin (LWMH) in rheumatic mitral stenosis (MS) patients with left atrial thrombus and percutaneous balloon mitral valvuloplasty (PBMV).